QIAGEN (QGEN)
Supplies sample technologies, molecular diagnostics, PCR and genomics tools for research and clinical testing.
$43.77
vs last close−1.01 (−2.26%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 66.01% | 143.19M ADS | |
|---|---|---|---|
| 364 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Other | ≈ 33.99% | 73.73M ADS | |
| remainder | |||
216.92M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
364 holders · 143.19M shares · 74 new positions · 212 increased · 96 reduced · 80 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Wellington Management Group LLP | 12.41M | 5.72% | −1.96M | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 11.35M | 5.23% | +2.93M | Aug 14, 2026 |
| Principal Financial Group Inc | 6.65M | 3.07% | +6.64M | Aug 4, 2026 |
| Vanguard Capital Management LLC | 6.21M | 2.86% | +103.6K | Aug 13, 2026 |
| BlackRock, Inc. | 5.91M | 2.72% | +655.2K | Aug 7, 2026 |
| Morgan Stanley | 5.04M | 2.32% | +851.5K | Aug 13, 2026 |
| Earnest Partners LLC | 4.57M | 2.11% | +705.0K | Aug 13, 2026 |
| Goldman Sachs Group Inc | 4.44M | 2.05% | +3.05M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Massachusetts Financial Services Company | 11.60% | 13G | May 14, 2025 | |
| BlackRock, Inc. | 10.20% | Nov 7, 2024 | ||
| Wellington Group Holdings LLPincl. Wellington Management Group LLP, Wellington Management Company LLP +1 more | 9.49% | 13G | Nov 8, 2024 | |
| Wellington Management Group LLP | 6.50% | 14.14M | 13G | Feb 10, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.